Access cutting-edge adhd treatment through this clinical trial at a research site in Long Beach. Study-provided care at no cost to qualified participants.
Access adhd specialists in Long Beach at no cost
This study follows strict safety protocols and ethical guidelines
All study-related adhd treatment provided free
This study will evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD.
Sponsor: Supernus Pharmaceuticals, Inc.
Check if you qualify for this adhd clinical trial in Long Beach, CA
If you're searching for adhd treatment options in Long Beach, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Long Beach research site is actively enrolling participants for this clinical trial. You'll receive care from experienced adhd specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.